OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program-Reference-Cited by-同舟云学术

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program

Published:2011-08-29 Issue:9 Volume:51 Page:1358-1373
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:

Author:

Aurora Sheena K.,Winner Paul,Freeman Marshall C.,Spierings Egilius L.,Heiring Jessica O.,DeGryse Ronald E.,VanDenburgh Amanda M.,Nolan Marissa E.,Turkel Catherine C.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1526-4610.2011.01990.x/fullpdf

Reference55 articles.

1. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II;Lipton;Headache,2001

2. Global prevalence of chronic migraine: A systematic review;Natoli;Cephalalgia,2010

3. The International Classification of Headache Disorders: 2nd edition;Cephalalgia,2004

4. New appendix criteria open for a broader concept of chronic migraine;Olesen;Cephalalgia,2006

5. Quality-of-life differences between patients with episodic and transformed migraine;Meletiche;Headache,2001

Cited by 249 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights from 25 years of onabotulinumtoxinA in migraine — mechanisms and management;Nature Reviews Neurology;2024-08-19

2. The safety and efficacy of onabotulinumtoxinA injections for children and adolescents with chronic migraine: A systematic review and meta‐analysis;Headache: The Journal of Head and Face Pain;2024-08-11

3. Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials;Headache: The Journal of Head and Face Pain;2024-06-22

4. A Risk-Difference Meta-Analysis for the Prophylactic Treatments of Chronic Migraine;Cureus;2024-06-16

5. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study;Frontiers in Neurology;2024-06-13